ArticleCancer research2026

Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma.

Justin D Clubb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.